Latest filing published 08 Aug 2012 for Ernexa Therapeutics Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -25.2%Entry US$952,500.00 · Close at T+365 US$712,500.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kendra Berger: trading record in brief
This profile gathers the share dealings of Kendra Berger in Ernexa Therapeutics Inc. We count 3 filings; the first trade dates from 31 August 2006 and the latest from 6 August 2012.
Purchases make up the whole of the open-market record (1 purchase, €20k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 share grants.
Most recently, on 8 August 2012, the filings show a share grant in Ernexa Therapeutics Inc. The clock since the last published purchase (1 September 2006) now reads 7,374 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kendra Berger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 150,000 shares0Common StockSEC:0001019687-12-002663:0
- 18,750 shares0Common stockSEC:0001181431-08-049427:0
- 20,000 shares@ US$1.28Common StockSEC:0001181431-06-050834:0Canonical exit: 29 Nov 2006 (T+90)
3 of 3 declarations
